Balyasny Asset Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,000
Closed -$667K 2809
2022
Q3
$667K Buy
+10,000
New +$634K ﹤0.01% 1951
2018
Q4
Sell
-80,000
Closed -$4.32M 1426
2018
Q3
$4.32M Buy
+80,000
New +$4.09M 0.02% 754
2018
Q1
Sell
-350,000
Closed -$21.4M 1965
2017
Q4
$21.4M Buy
+350,000
New +$21.6M 0.07% 377
2017
Q1
Sell
-113,300
Closed -$8.15M 1598
2016
Q4
$8.15M Buy
+113,300
New +$8.19M 0.04% 543

Other funds holding CAH

Balyasny Asset Management's CAH Position: Q1 2026 in Review

Balyasny Asset Management increased its Cardinal Health (CAH) stake by 21% in Q1 2026, buying an estimated $5.31M and bringing the position to 143,560 shares worth $30.3M. The position accounts for 0.04% of the portfolio, ranked #522.

Balyasny Asset Management first reported a position in CAH in Q2 2013 and has held it in 37 quarters since. The position peaked at $110M in Q1 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Balyasny Asset Management held 143,560 shares of Cardinal Health worth $30.3M as of Q1 2026.
  • Balyasny Asset Management bought 24,637 Cardinal Health shares in Q1 2026, an estimated $5.31M.
  • Cardinal Health made up 0.04% of Balyasny Asset Management's portfolio in Q1 2026, its #522 holding.
  • Balyasny Asset Management first reported a position in Cardinal Health in Q2 2013 and has held it in 37 quarters since.
  • Balyasny Asset Management's Cardinal Health position peaked at $110M in Q1 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.